go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

ZPP Dentalmedizintechnik GmbH

Organization type
RDM medtech
Region
Styria
Topic
dental devices
Details

MRD PHYSICOM Medical Research and Development Physicom GmbH

Organization type
RDM medtech
Region
Upper Austria
Cluster
Medical Technology Cluster
Topic
Other
Details

Pharma Consult Ges.m.b.H.

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
Other
Details

Phoenix Cryo Therapeutics GmbH

Organization type
RDM medtech
Region
Tyrol
Topic
Other
Details

Contact



Contact: